Effects of Natalizumab and Fingolimod on Clinical, Cognitive, and Magnetic Resonance Imaging Measures in Multiple Sclerosis

Paolo Preziosa; Maria A. Rocca; Gianna Carla Riccitelli; Lucia Moiola; Loredana Storelli; Mariaemma Rodegher; Giancarlo Comi; Alessio Signori; Andrea Falini; Massimo Filippi

doi:10.1007/s13311-019-00781-w

Related publications

Article2017

The Effects of Natalizumab and Fingolimod on Clinical and MRI Measures in Relapsing Remitting Multiple Sclerosis: A Two-Year Comparative Study (P2.073)

Paolo Preziosa, Maria A. Rocca, Gianna Carla Riccitelli, Mariaemma Rodegher, Lucia Moiola, Andrea Falini, Giancarlo Comi, Massimo Filippi

Article2015

The Effects of Natalizumab and Fingolimod on Clinical, Neuropsychological and MRI Measures in Relapsing Remitting Multiple Sclerosis: A One-Year Comparative Study (P6.152)

Paolo Preziosa, Maria A. Rocca, Gianna Carla Riccitelli, Mariaemma Rodegher, Massimiliano Copetti, Lucia Moiola, Francesco Mele, Andrea Falini, Giancarlo Comi, Massimo Filippi

Article1998

Clinical, neurophysiological, and magnetic resonance imaging correlations in multiple sclerosis.

Giancarlo Comi, Massimo Filippi, Marco Rovaris, Letizia Leocani, S. Medaglini, T. Locatelli

Article1993

Brain magnetic resonance imaging correlates of cognitive impairment in multiple sclerosis

Gıancarlo Comı, Massimo Filippi, Vittorio Martinelli, G. Sirabian, A. Visciani, A. Campi, S. Mammì, Marco Rovaris, N. Canal

Article2021

Quantitative magnetic resonance imaging towards clinical application in multiple sclerosis

Cristina Granziera, Jens Wuerfel, Frederik Barkhof, Massimiliano Calabrese, Nicola De Stefano, Christian Enzinger, Nikos Evangelou, Massimo Filippi, Jeroen J.G. Geurts, Daniel S. Reich, Maria A. Rocca, Stefan Ropele, Àlex Rovira, Pascal Sati, Ahmed Toosy, Hugo Vrenken, Claudia A. M. Gandini Wheeler‐Kingshott, Ludwig Kappos, Frederik Barkhof, Nicola De Stefano, Jaume Sastre‐Garriga, Olga Ciccarelli, Christian Enzinger,